Private equity investors in Switzerland
Updated 16 Nov 2026
Venture funds
2 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Lakestar Lakestar invests in technology companies led by exceptional entrepreneurs, recently backing Dexory and constellr. Zürich, Switzerland |
Fintech, Artificial intelligence | Seed, Early stage venture, Late stage venture | 34% | 6 |
| 2 | Nextech Invest Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio. Zürich, Switzerland |
Health care, Biotech | Early stage venture, Late stage venture | 31% | 2 |
Table 1. Private equity investors in Switzerland: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | •••@hbmhealthcare.com | +41 41••• |
| Lakestar | Venture capital firm | Zürich, Switzerland | •••@lakestar.com | (503) ••• |
| UBS | Corporate venture arm | Zürich, Switzerland | •••@ubs.com | 41 44 ••• |
| VI Partners | Venture capital firm | Altendorf, Switzerland | •••@vipartners.ch | +41 41••• |
| Nextech Invest | Venture capital firm | Zürich, Switzerland | •••@nextechinvest.com | 41 (0)••• |
| Blue Horizon Corporation | Private equity firm | Zürich, Switzerland | •••@bluehorizon.com | |
| responsAbility Investments AG | Fund of funds | Zürich, Switzerland | •••@responsability.com | +41 44••• |
| Partners Group | Private equity firm | Baar, Switzerland | •••@partnersgroup.com | 212 90••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 93 of the 161 private equity investors in Switzerland have a published email address, 73 a phone number and 146 a website.
- HBM Healthcare Investments has the most recorded investments, 260, 47 of them as lead investor.
- 9 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Lakestar is an investor in 6 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Basecamp Research's $140.0M Series C on 23 September 2026.
- Software is the most common sector across their 209 portfolio companies (69%).
- Early stage venture is the most common investment stage, recorded for 67 of them (42%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Private equity investors in Switzerland
30 of 161, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | Biotech, Health care | 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics | 260 | 47 | 90 | •••@hbmhealthcare.com | +41 41••• | ||
| 2 | Lakestar | Venture capital firm | Zürich, Switzerland | Fintech, Artificial intelligence | Mindgard, Firenze, Dexory | 6 | 228 | 77 | 34 | •••@lakestar.com | (503) ••• | In the CSV |
| 3 | UBS | Corporate venture arm, Fund of funds | Zürich, Switzerland | Fintech, Hardware | SWISSto12, MerQube, Nasdaq Private Market | 3 | 157 | 53 | 53 | •••@ubs.com | 41 44 ••• | In the CSV |
| 4 | VI Partners | Venture capital firm | Altendorf, Switzerland | Health care, Biotech | L.E.S.S. | 1 | 111 | 26 | 22 | •••@vipartners.ch | +41 41••• | In the CSV |
| 5 | Nextech Invest | Venture capital firm | Zürich, Switzerland | Health care, Biotech | Circle Pharma, Atavistik Bio | 2 | 100 | 31 | 43 | •••@nextechinvest.com | 41 (0)••• | In the CSV |
| 6 | Blue Horizon Corporation | Private equity firm, Venture capital firm | Zürich, Switzerland | Commerce, Health care | Basecamp Research | 1 | 78 | 20 | 5 | •••@bluehorizon.com | In the CSV | |
| 7 | responsAbility Investments AG | Fund of funds, Private equity firm | Zürich, Switzerland | Fintech, Commerce | Koa Switzerland, Investree, ePaylater | 74 | 42 | 11 | •••@responsability.com | +41 44••• | In the CSV | |
| 8 | Partners Group | Private equity firm | Baar, Switzerland | Hardware, Artificial intelligence | Neara, Akur8, Sirion | 74 | 39 | 34 | •••@partnersgroup.com | 212 90••• | In the CSV | |
| 9 | Endeavour Vision | Venture capital firm | Geneva, Switzerland | Biotech, Health care | Kobojo, OncoEthix, Symetis | 68 | 19 | 22 | •••@endeavourvision.com | +41 22••• | In the CSV | |
| 10 | BlueOrchard Finance S A | Private equity firm, Venture debt fund | Geneva, Switzerland | Fintech | Pula Advisors | 49 | 35 | 8 | •••@blueorchard.com | 22 596••• | In the CSV | |
| 11 | Credit Suisse First Boston | Investment bank | Zürich, Switzerland | 48 | 6 | 25 | +41 1-••• | In the CSV | ||||
| 12 | BB Biotech Ventures | Venture capital firm | Zürich, Switzerland | Biotech, Health care | Alpex Pharma, Pevion Biotech | 48 | 5 | 13 | •••@bellevue.ch | +41 44••• | ||
| 13 | Dr. Cornelius Boersch | Angel investor, Investment partner | Zürich, Switzerland | Commerce, Fintech | ModelManagement.com, gini, Secucloud | 48 | 2 | 17 | In the CSV | |||
| 14 | Symbiotics Group | Private equity firm | Geneva, Switzerland | Fintech | KiWi | 43 | 27 | 8 | •••@symbioticsgroup.com | +65 31••• | In the CSV | |
| 15 | ACE & Company | Private equity firm, Secondary purchaser | Geneva, Switzerland | Cybersecurity | Infrascreen, Pledge, Slauth.io | 41 | 3 | 6 | •••@aceandcompany.com | +41 (0••• | In the CSV | |
| 16 | Aeris Capital | Private equity firm | Pfaffikon, Switzerland | 39 | 15 | 12 | In the CSV | |||||
| 17 | Wille Finance | Family office, Private equity firm | Zürich, Switzerland | Health care, Biotech | Incepto Medical | 1 | 38 | 5 | 5 | •••@willefinance.com | +41 44••• | In the CSV |
| 18 | Schroder Adveq | Private equity firm | Zürich, Switzerland | Software | eCheng | 34 | 4 | 9 | •••@schroderadveq.com | +44 20••• | In the CSV | |
| 19 | Blue Earth Capital | Private equity firm | Baar, Switzerland | Energy, Artificial intelligence | Quatt.io, TS Conductor, Reev | 32 | 19 | 3 | •••@blueearth.capital | 41 41 ••• | In the CSV | |
| 20 | FortyOne Group | Private equity firm | Saint Gallen, Switzerland | Fintech, Health care | Meteomatics, Matriq, memox. | 24 | 6 | 4 | •••@41group.ch | +41 71••• | In the CSV | |
| 21 | Storm Global | Private equity firm, Venture capital firm | Zürich, Switzerland | Artificial intelligence | Ople | 24 | 1 | 13 | In the CSV | |||
| 22 | Invision Private Equity AG | Private equity firm, Venture capital firm | Zug, Switzerland | Software | apps4biz.com | 23 | 8 | 8 | •••@invision.ch | In the CSV | ||
| 23 | MTIP AG | Private equity firm | Basel, Switzerland | Health care, Artificial intelligence | NitiNotes, Hexarad, Apricity | 22 | 13 | 4 | •••@mtip.ch | +41615••• | In the CSV | |
| 24 | SAGANA | Family office, Private equity firm | Zürich, Switzerland | Biotech, Hardware | inHEART | 20 | 2 | 2 | •••@sagana.com | +41 79••• | In the CSV | |
| 25 | BRAZENHALO | Private equity firm, Venture capital firm | Lucerne, Switzerland | 18 | 18 | 0 | •••@brazenhalo.com | In the CSV | ||||
| 26 | Alphamundi | Private equity firm | Zürich, Switzerland | 18 | 4 | 1 | •••@alphamundi.ch | In the CSV | ||||
| 27 | Sygnum | Private equity firm | Zürich, Switzerland | Hardware, Artificial intelligence | Bluwhale, ZATAP, P2P Validator | 16 | 9 | 4 | •••@sygnum.com | +41 58••• | In the CSV | |
| 28 | Capital Transmission | Private equity firm | Geneva, Switzerland | Cybersecurity, Artificial intelligence | ELCA, Ascend Sport Technology | 16 | 1 | 4 | +41 (0••• | In the CSV | ||
| 29 | Capvis | Private equity firm | Baar, Switzerland | 13 | 2 | 6 | •••@capvis.com | +41433••• | In the CSV | |||
| 30 | C Capital | Hedge fund, Private equity firm | Lausanne, Switzerland | 12 | 4 | 0 | •••@youngtimers.com | 41 615••• | In the CSV |
Table 2. Private equity investors in Switzerland: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 161.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Lakestar | Zürich, Switzerland | 6 | 49 | Mindgard, Firenze, Dexory |
| 2 | UBS | Zürich, Switzerland | 3 | 26 | SWISSto12, MerQube, Nasdaq Private Market |
| 3 | Nextech Invest | Zürich, Switzerland | 2 | 5 | Circle Pharma, Atavistik Bio |
| 4 | Blue Horizon Corporation | Zürich, Switzerland | 1 | 8 | Basecamp Research |
| 5 | Wille Finance | Zürich, Switzerland | 1 | 9 | Incepto Medical |
| 6 | Haute Capital Partners | Biel, Switzerland | 1 | 1 | Aisot Technologies |
| 7 | LifeCare Partners | Basel, Switzerland | 1 | 1 | Kupando |
| 8 | VI Partners | Altendorf, Switzerland | 1 | 19 | L.E.S.S. |
| 9 | Wecken & Cie. | Basel, Switzerland | 1 | 6 | happyhotel |
Table 3. Private equity investors in Switzerland: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Basecamp Research | Basecamp Research is a biotechnology company that uses AI and biological data to develop therapeutics. | Artificial intelligence | London, United Kingdom | Series C | $140.0M | 2026-09-23 | $219.9M | Blue Horizon Corporation | 51 to 100 | 2019 |
| Incepto Medical | Incepto Medical develops artificial intelligence software for medical imaging. | Artificial intelligence | Paris, France | Series B | $16.0M | 2026-09-22 | $49.2M | Wille Finance | 51 to 100 | 2018 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco, United States | Series E | $92.5M | 2026-09-16 | $300.0M | Nextech Invest | 11 to 50 | 2012 |
| Aisot Technologies | Aisot Technologies provides predictive AI software to help asset managers make better investment decisions. | Fintech | Zürich, Switzerland | Seed | $2.5M | 2026-08-13 | $4.9M | Haute Capital Partners | 1 to 10 | 2021 |
| Mindgard | Mindgard provides AI Red Teaming solutions to identify and mitigate vulnerabilities in artificial intelligence systems. | Artificial intelligence | Boston, United States | Series A | $30.0M | 2026-08-12 | $41.9M | Lakestar | 11 to 50 | 2022 |
| SWISSto12 | SWISSto12 designs, manufactures, and integrates radio frequency products for commercial and government customers. | Hardware | Renens, Switzerland | Series C | $70.0M | 2026-07-16 | $202.3M | UBS | 251 to 500 | 2011 |
| Firenze | Firenze is a financial services company that offers investment-backed lending to a broader customer base. | Fintech | Manchester, United Kingdom | Series A | $8.1M | 2026-04-21 | $215.0M | Lakestar | 1 to 10 | 2023 |
| MerQube | MerQube provides technology for rules-based investment strategies and passive index design. | Fintech | San Francisco, United States | Series C | $30.0M | 2026-04-13 | $67.0M | UBS | 51 to 100 | 2019 |
| Dexory | Dexory uses autonomous robots and artificial intelligence to capture real-time warehouse operations insights. | Artificial intelligence | London, United Kingdom | Series C | $11.4M | 2026-03-26 | $294.3M | Lakestar | 51 to 100 | 2015 |
| Kupando | Kupando is a biopharmaceutical company developing agonists that stimulate innate immunity. | Biotech | Schönefeld, Germany | Series A | $11.5M | 2026-03-18 | $24.0M | LifeCare Partners | 1 to 10 | 2018 |
Table 4. Private equity investors in Switzerland: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 145 | 69% |
| Fintech | 56 | 27% |
| Artificial intelligence | 46 | 22% |
| Health care | 40 | 19% |
| Hardware | 29 | 14% |
| Biotech | 28 | 13% |
| Commerce | 19 | 9% |
| Cybersecurity | 10 | 5% |
| Education | 6 | 3% |
| Energy | 5 | 2% |
Table 5. Private equity investors in Switzerland: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Private equity investors | 161 | 100% |
| Early stage investors | 67 | 42% |
| Venture investors | 58 | 36% |
| Late stage investors | 52 | 32% |
| Seed investors | 52 | 32% |
| Debt investors | 29 | 18% |
| Convertible note investors | 21 | 13% |
| Secondary market investors | 19 | 12% |
Table 6. Private equity investors in Switzerland by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 7. Private equity investors in Switzerland by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 13 | 11% |
| 2010s | 48 | 42% |
| 2000s | 29 | 25% |
| 1990s | 17 | 15% |
| 1980s | 3 | 3% |
| 1970s | 3 | 3% |
Table 8. Private equity investors in Switzerland by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include private equity investors and its headquarters is in Switzerland. On 16 November 2026 that is 161 investors.
- 93 rows carry an email address and 73 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 161 rows: 15 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many private equity investors in Switzerland are on the list?
- 161, in the file dated 16 November 2026. 9 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 93 of the 161 carry an email address in the download and 73 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 161 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 161 rows, 93 firm email addresses and 73 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 78 of the 93 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.